|
Table 1: Prevalence of HBP according to diverse national surveys. |
||||||||
|
|
ENEC 1993 |
ENSA 2000 |
ENSANUT 2006 |
ENSANUT 2012 |
ENSANUT MC 2016 |
ENSANUT-100 K 2018 |
ENSANUT 2020 |
ENSANUT 2022 |
|
Women |
140/90 28.1% |
140/90 26.3% |
140/90 31.1%/47.3%* |
140/90 30.8% |
140/90 26.1% |
140/90 33.8% 130/80 46.8% |
140/90 28.6% 130/80 44% |
140/90 27.7% 130/80 42.4% |
|
Men |
140/90 37.5% |
140/90 34.2% |
140/90 32.4%/40.3%* |
140/90 33.3% |
140/90 24.9% |
140/90 31.4% 130/80 52.2% |
140/90 31.9% 130/80 53% |
140/90 31.3% 130/80 53.8% |
|
Total |
140/90 32.8% |
140/90 30.5% |
140/90 30.8%/43.2%* |
140/90 32% |
140/90 25.5% |
140/90 32.7% 130/80 49.2% |
140/90 30.2% 130/80 49.4% |
140/90 29.4% 130/80 47.8% |
|
ENEC = National Survey on Chronic Diseases. ENSA = National Health Survey. E NSANUT = National Health, and Nutrition Surveys. MC = halfway. 100 K = towns of less than 100,000 inhabitants. Cutoffs for diagnosing HBP: 140/90 (JNC 7) or 130/80 (ACC/AHA). * Data from ENSANUT 2006: the first number corresponds to the official report, and the numbers with a single asterisk indicate those published in an article written by the same investigators.6,17 |
||||||||